封面
市場調查報告書
商品編碼
1624970

2024 年至 2031 年直接面向消費者的基因檢測市場(按檢測類型、技術、最終用戶和地區劃分)

Direct-To-Consumer (DTC) Genetic Testing Market By Test Type (Carrier Testing, Predictive Testing), By Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips), By End-User (Laboratories, Hospitals, Home Care), & Region for 2024-2031

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年至 2031 年直接面向消費者的基因檢測市場估值

直接面向消費者(DTC)的基因檢測市場正在快速成長。人們對個人化醫療保健和保健的興趣日益濃厚。消費者對自己的健康越來越積極主動,而DTC測試可以提供有關一個人獨特基因組成的資訊。這些知識可以幫助人們根據其獨特的生物學特性制定有關營養、運動甚至疾病預防的明智決定。預計各種組織將推動市場規模,預計到 2024 年將超過 14.3 億美元,到 2031 年估值達到約 38.6 億美元。

此外,人們對遺傳疾病的認識不斷提高以及對預防措施的重視也推動了 DTC 檢測的需求。對具有成本效益且高效的直接面向消費者 (DTC) 基因檢測的需求不斷增長,推動市場在 2024 年至 2031 年期間的複合年增長率達到 13.25%。

直接面向消費者的基因檢測市場:定義與概述

直接面向消費者(DTC)基因測試是指直接銷售給消費者的測試,無需醫療保健專業人員的參與。這些測試通常評估一個人的 DNA,以確定祖先、遺傳特徵、某些疾病的遺傳易感性,以及在某些情況下的治療反應。提供 DTC 基因測試的公司通常會向消費者提供試劑盒,然後消費者收集 DNA 樣本(通常是唾液)並將其送回公司進行分析。結果通常可以在線或透過行動應用程式獲得,並且通常包括解釋和建議。

DTC 基因檢測由於其簡單性以及它可能提供有關個人健康和遺傳的洞察力而越來越受歡迎。消費者對自己患有阿茲海默症、癌症和心臟病等疾病的遺傳易感性感到好奇,這些疾病可能會影響他們的生活方式選擇並推動積極的醫療保健決策。另一個流行的應用是祖先測試,它可以讓人們更多地瞭解他們的遺傳遺產並與遠親建立聯繫。

全基因組定序成本的降低等技術進步可能會提高這些測試所提供的資訊的準確性和範圍。與電子病歷和私人執業醫生的整合可能會改善臨床實踐中對遺傳數據的解釋和使用。然而,人們仍然擔心解釋的準確性、基因數據的隱私以及直接獲取敏感健康資訊可能造成的心理影響。DTC 基因檢測的監管和監督可能會不斷發展,以解決這些問題,同時保持消費者獲取有用基因發現的管道。

日益增強的消費者意識如何推動直接面向消費者的基因檢測市場的發展?

提高消費者知識是直接面向消費者(DTC)基因檢測市場的主要驅動力。隨著越來越多的人意識到瞭解自己的健康風險、優化治療方案和做出明智的生活方式選擇的潛在益處,對基因檢測服務的需求預計會增加。宣傳活動、教育活動和媒體報告對於讓大眾瞭解直接面向消費者的 DNA 檢測 (DTC) 的可用性、價格和可及性至關重要。認知度的提高不僅會透過吸引新客戶擴大市場,還會激勵現有用戶探索其他遺傳見解,例如家譜和量身定制的健康計劃。

根據美國國家醫學圖書館的資料,直接面向消費者(DTC)的基因測試通常透過網路直接出售給消費者,無需醫療保健專業人員的參與。此次試驗引起了正面和負面的關注。2008 年,《時代》雜誌將 23andMe 的 DTC 全基因組掃瞄評為 "年度創新" 。DTC 基因檢測網站通常連結到科學研究,並可能包括用戶論壇等互動功能。2012年,一次典型的測試花費數百美元。2011 年,23andMe 報告其銷售了 10 萬份全基因組掃瞄數據。

隨著個人化醫療保健和健康的趨勢日益增長以及重點轉向個人化醫療保健和健康,對 DTC 基因檢測的需求也日益增長。消費者越來越有興趣瞭解自己的基因組成,以便做出更明智的生活方式、疾病預防和治療決定。個人可以從 DTC 基因檢測中受益,因為它提供了有關一個人獨特基因特徵的重要信息,使他們能夠採取更加個性化的方法來治療自己的健康。

法規和道德問題會影響直接面向消費者的基因檢測市場的成長嗎?

直接面向消費者(DTC)基因檢測市場的監管和道德考量可能會對其擴張產生重大影響。監管課題,例如對基因測試結果的準確性、解釋和報告的不同要求,可能會阻礙市場進入和擴張。對隱私保護和基因資料安全儲存的不確定性增加了消費者的不信任和監管擔憂。

關於基因資訊的適當使用和解釋的倫理問題、對消費者的潛在心理影響以及對基因歧視的擔憂都使市場動態變得複雜。透過透明的方式、強有力的資料保護措施和有效的監管框架解決這些問題將有助於建立客戶信任並確保 DTC 基因檢測市場的長期成功。

共享 DNA 引發了道德和隱私問題。消費者擔心DTC公司會非法取得資料、洩漏資料或濫用他們的基因訊息,阻礙市場成長。成本和報銷問題 DTC 測試費用昂貴,保險覆蓋範圍可能有限。對於許多潛在客戶來說,這可能會成為進入的障礙。

目錄

第 1 章 簡介

  • 市場定義
  • 市場細分
  • 調查方法

第 2 章執行摘要

  • 主要發現
  • 市場概況
  • 市集亮點

第3章市場概況

  • 市場規模和成長潛力
  • 市場趨勢
  • 市場驅動力
  • 市場制約因素
  • 市場機會
  • 波特五力分析

4. DTC 基因檢測市場依檢測類型劃分

  • 攜帶者檢測
  • 預測測試
  • 家庭和譜系測試
  • 營養基因組學測試

第5章 DTC 基因檢測市場(依技術)

  • 目標分析
  • 單核甘酸多態性(SNP)晶片
  • 全基因組定序(WGS)

第6章 區域分析

  • 北美
  • 美國
  • 加拿大
  • 墨西哥
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 智利
  • 中東/非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合酋長國

第7章 市場動態

  • 市場驅動力
  • 市場制約因素
  • 市場機會
  • COVID-19 的市場影響

第8章 競爭格局

  • 大公司
  • 市場佔有率分析

第9章 公司簡介

  • 23andMe
  • Ancestry
  • Color Genomics
  • Helix
  • Living DNA
  • EasyDNA
  • Full Genome Corporation
  • Genesis Healthcare
  • Family Tree DNA(Gene By Gene)
  • MyHeritage

第10章市場前景與機遇

  • 新興技術
  • 未來市場趨勢
  • 投資機會

第11章 附錄

  • 縮寫表
  • 來源和參考文獻
簡介目錄
Product Code: 25584

Direct-To-Consumer (DTC) Genetic Testing Market Valuation - 2024-2031

The market for direct-to-consumer (DTC) genetic testing is growing rapidly. There is an increasing interest in individualized healthcare and wellness. Consumers are becoming more proactive about their health, and DTC testing provides information about their unique genetic composition. This knowledge can help people make informed decisions regarding nutrition, exercise, and even disease-preventive techniques, adapting their approach to their particular biology. The various organizations is driving the market size to surpass USD 1.43 Billion in 2024 to reach a valuation of aroundUSD 3.86 Billion by 2031.

Furthermore, rising awareness of genetic disorders and a focus on preventative measures are driving demand for DTC testing. The rising demand for cost-effective and efficient direct-to-consumer (DTC) genetic testing is enabling the market grow at aCAGR of 13.25% from 2024 to 2031.

Direct-To-Consumer (DTC) Genetic Testing Market: Definition/ Overview

Direct-to-consumer (DTC) genetic testing refers to tests that are sold directly to consumers without the involvement of healthcare experts. These tests often evaluate a person's DNA to determine ancestry, inherited traits, genetic predispositions to particular diseases, and, in some cases, treatment reactions. Companies that provide DTC genetic testing typically deliver a kit to the consumer, who then collects a DNA sample (usually saliva) and returns it to the company for analysis. Results are often made available online or via a mobile app and are frequently accompanied by interpretations and recommendations.

DTC genetic testing has grown in popularity due to its simplicity and the possible insights it provides about personal health and heritage. Consumers are curious about their genetic predispositions to diseases such as Alzheimer's, cancer, and heart disease, which could influence lifestyle choices or encourage proactive healthcare decisions. Another popular application is ancestry testing, which allows people to learn more about their genetic heritage and connect with distant relatives.

Technological advancements, such as the lower cost of whole genome sequencing, may improve the accuracy and range of information offered by these tests. Integration with electronic health records and medical practitioners may improve the interpretation and use of genetic data in clinical settings. However, worries persist about the accuracy of interpretations, the privacy of genetic data, and the potential psychological consequences of getting sensitive health information directly. Regulation and monitoring of DTC genetic testing will most likely evolve to meet these concerns while maintaining consumer access to useful genetic insights.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How Increasing Consumer Awareness Driving the Direct-To-Consumer (DTC) Genetic Testing Market?

Increasing consumer knowledge is a major driver of the Direct-to-Consumer (DTC) genetic testing market. Demand for genetic testing services is expected to increase as more individuals become aware of its potential benefits for understanding their health risks, optimizing medical treatments, and making educated lifestyle choices. Awareness campaigns, educational initiatives, and media coverage are critical in alerting the public about the availability, price, and accessibility of direct-to-consumer DNA testing (DTC). This increased awareness not only broadens the market by hiring new customers but also motivates current users to investigate other genetic insights, such as ancestry and tailored wellness programs, thus boosting market growth.

According to the National Library of Medicine, Direct-to-consumer (DTC) genetic tests are sold directly to consumers, without the involvement of a healthcare professional, usually through the Internet. The tests have garnered both favorable and negative attention. In 2008, Time Magazine dubbed 23andMe's DTC whole genome scan the 'Innovation of the Year.' DTC genetic testing websites frequently link to scientific studies and may include interactive features like user forums. In 2012, the typical cost for the testing was several hundred dollars. In 2011, 23andMe reported that the company had sold 100,000 full genome scans.

Increasing Personalized Healthcare and Wellness Trends, the need for DTC genetic testing is expanding as the focus shifts to personalized healthcare and wellness. Consumers are becoming increasingly interested in understanding their genetic makeup to make more informed lifestyle, disease preventive, and treatment decisions. Individuals benefit from DTC genetic testing because it provides significant information about their unique genetic profile, allowing them to take a more personalized approach to their health.

Will Regulatory and Ethical Concerns Impact the Growth of the Direct-to-Consumer (DTC) Genetic Testing Market?

The Direct-to-Consumer (DTC) genetic testing market regulatory and ethical considerations could have a substantial impact on the expansion. Regulatory difficulties, such as different requirements for the accuracy, interpretation, and reporting of genetic test findings, might impede market entry and expansion. Uncertainties about privacy protections and the secure storage of genetic data add to consumer distrust and regulatory concerns.

Ethical difficulties regarding the proper use and interpretation of genetic information, potential psychological effects on consumers, and worries about genetic discrimination all complicate market dynamics. Addressing these concerns through transparent methods, strong data protection measures , and effective regulatory frameworks will be essential for establishing customer trust and guaranteeing long-term success in the DTC genetic testing market.

Sharing DNA poses ethical and privacy concerns. Consumers are concerned about DTC companies gaining illegal access, committing data breaches, or misusing their genetic information, which might impede market growth. Cost and Reimbursement Issues DTC testing is expensive, and insurance coverage may be limited. This can be a barrier to entrance for many prospective clients.

Category-Wise Acumens

Will Heritage and Familial Connections Propel the Ancestry & Relationship Testing Segment for the Direct-to-Consumer (DTC) Genetic Testing Market?

The Direct-to-Consumer (DTC) genetic testing market, the Ancestry & Relationship Testing section is fueled by a strong desire to learn about one's ancestors and family relationships. Ancestry & Relationship Testing dominates the DTC genetic testing market. Many people are very interested in learning about their genetic ancestry, discovering ancestral roots, and connecting with distant relatives. This fascination stems from a combination of personal interest in family history, cultural identification, and the compelling narratives supplied by genealogy. Furthermore, the capacity to find unknown relatives and create family trees using shared genetic data increases the appeal of these services.

The fastest-growing area is expected to be nutrigenomic testing. This part is aimed at a health-conscious audience interested in improving their diet and wellness depending on their genetic composition. As consumers become more aware of the link between genes and diet, they are looking for individualized information to help them improve their health. This area is expected to develop as there is a greater emphasis on preventative measures and a proactive approach to wellbeing.

Will Cost-Effectively Signify the Single Nucleotide Polymorphism (SNP) Chips for the Direct-to-Consumer (DTC) Genetic Testing Market?

In the realm of DTC genetic testing technology, Single Nucleotide Polymorphism (SNP) Chips currently reign supreme. Cost-effectiveness is a key factor driving the use of Single Nucleotide Polymorphism (SNP) chips in the Direct-to-Consumer (DTC) genetic testing market. SNP chips are a very inexpensive means of studying genetic variants across an individual's genome, making them available to a larger user base. These chips allow for the detection of a wide range of genetic markers associated with health, characteristics, and ancestry at a lower cost than whole-genome sequencing. The low cost of SNP chip technology enables DTC genetic testing companies to provide comprehensive genetic insights at a mass market price point, resulting in widespread adoption and market growth.

Whole Genome Sequencing (WGS) may reign supreme in terms of rapid expansion. WGS provides the most thorough analysis by understanding an individual's full genetic code. While more expensive than SNP chips, WGS has enormous potential for future uses. As technology becomes more inexpensive and data interpretation methods improve, WGS is expected to gain popularity. This is owing to its ability to detect a broader spectrum of genetic variants and perhaps provide a more complete picture of a person's health risk.

Country/Region-wise Acumens

Will the High Concentration of Direct-to-Consumer (DTC) Genetic Testing Market Propel the North America?

In the DTC genetic testing market, North America now enjoys a strong position. The high concentration of the Direct-to-Consumer (DTC) genetic testing market is expected to stimulate growth in North America. The region's modern healthcare infrastructure, high consumer awareness, and large disposable income all contribute to a high demand for genetic testing services.

Furthermore, the presence of major direct-to-consumer genetic testing companies, as well as supporting legislative frameworks and substantial technology innovations, contribute to market expansion. North America's leadership in genomics research and innovation is also critical to driving the adoption and development of direct-to-consumer genetic testing, making it a vital market for growth in this sector.

A big population with disposable income is interested in personalized medicine. Furthermore, North America has a strong culture of preventative healthcare and genetic awareness, which drives market growth.

Will Increasing Internet Penetration Lead the Asian Pacific to the Direct-to-Consumer (DTC) Genetic Testing Market?

The baton of quickest growth is going to be passed to the Asia Pacific region. The growing internet penetration is an essential component of the Direct-to-Consumer (DTC) genetic testing market in Asia-Pacific. As internet availability expands, particularly in emerging nations, more people will be able to research and purchase DTC genetic testing services online. The simplicity of accessing information, ordering tests, and receiving results via digital platforms makes genetic testing more accessible to a greater audience.

This region is experiencing a convergence of forces fueling market expansion. Rising disposable income, increased internet penetration, and increased health and wellness consciousness are creating a fertile field for direct-to-consumer genetic testing. Furthermore, numerous Asian countries have large, young populations who are particularly open to innovative technologies and individualized healthcare techniques. This, combined with a fast-rising healthcare infrastructure, is projected to propel the business forward in this region.

Competitive Landscape

The Direct-To-Consumer (DTC) Genetic Testing Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the Direct-To-Consumer (DTC) Genetic Testing Market include:

  • EasyDNA
  • Ancestry

23andMe, Inc.

  • Color Health, Inc.
  • Genesis HealthCare
  • Full Genomes Corporation, Inc.
  • Helix OpCo LLC
  • Living DNA Ltd
  • Mapmygenome
  • GenomeWeb
  • Gene by Gene, Ltd.
  • MyHeritage Ltd.

10x Genomics

  • Dante Labs, Inc.

24Genetics

  • Laboratory Corporation of America Holdings
  • Myriad Genetics, Inc.
  • Quest Diagnostics Incorporated
  • Uniogen Oy

Latest Developments

  • In April 2023, Genesis Healthcare Co.'s GeneLife brand launched Haplo 3.0 in Japan, marking a significant advance to its ancestry services.
  • In July 2023, Quest Diagnostics debuted its first DTC-GT, Genetic Insights. The test analyzes a saliva sample to determine the risk of up to 24 genetically inheritable diseases, including colon and breast cancer, blood and heart issues, cystic fibrosis carrier status, sickle cell anemia, and Tay-Sachs disease.
  • In January 2022, 23andMe Holding Co., a prominent consumer genetics and research firm, was granted FDA approval for a genetic health risk report on a hereditary prostate cancer marker.

TABLE OF CONTENTS

1. Introduction

  • Market Definition
  • Market Segmentation
  • Research Methodology

2. Executive Summary

  • Key Findings
  • Market Overview
  • Market Highlights

3. Market Overview

  • Market Size and Growth Potential
  • Market Trends
  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Porter's Five Forces Analysis

4. Direct-To-Consumer (DTC) Genetic Testing Market, By Test Type

  • Carrier Testing
  • Predictive Testing
  • Ancestry & Relationship Testing
  • Nutrigenomic Testing

5. Direct-To-Consumer (DTC) Genetic Testing Market, By Technology

  • Targeted Analysis
  • Single Nucleotide Polymorphism (SNP) Chips
  • Whole Genome Sequencing (WGS)

6. Regional Analysis

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Latin America
  • Brazil
  • Argentina
  • Chile
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

7. Market Dynamics

  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Impact of COVID-19 on the Market

8. Competitive Landscape

  • Key Players
  • Market Share Analysis

9. Company Profiles

  • 23andMe
  • Ancestry
  • Color Genomics
  • Helix
  • Living DNA
  • EasyDNA
  • Full Genome Corporation
  • Genesis Healthcare
  • Family Tree DNA (Gene By Gene)
  • MyHeritage

10. Market Outlook and Opportunities

  • Emerging Technologies
  • Future Market Trends
  • Investment Opportunities

11. Appendix

  • List of Abbreviations
  • Sources and References